Cargando…

Challenges of patients with multiple sclerosis in receiving health care services in Iran

Background: Multiple sclerosis (MS) is a debilitating, non-traumatic, neurological disorder in young adults and can reduce quality of life (QoL) by interfering with the ability to work, leisure activities, and routine living tasks. Various studies have shown the dissatisfaction of people with MS in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahromi, Niloofar, Eskandarieh, Sharareh, Maleki, Nazanin, Sistany-Allahabadi, Narges, Sahraian, Mohammad Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444591/ https://www.ncbi.nlm.nih.gov/pubmed/38011340 http://dx.doi.org/10.18502/cjn.v22i1.12612

Ejemplares similares

Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999–2015
por: Eskandarieh, Sharareh, et al.
Publicado: (2018)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran
por: ESKANDARIEH, Sharareh, et al.
Publicado: (2017)

Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran
por: Omrani, Mohammad Amin, et al.
Publicado: (2023)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series
por: Amini, Payam, et al.
Publicado: (2021)

Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021)
por: Razazian, Nazanin, et al.
Publicado: (2023)

Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study
por: Kamali, Hoda, et al.
Publicado: (2022)

Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018
por: Almasi-Hashiani, Amir, et al.
Publicado: (2020)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review
por: Maroufi, Hossein, et al.
Publicado: (2021)

Medical history risk factors in primary progressive multiple sclerosis: A case-control study
por: Maroufi, Hossein, et al.
Publicado: (2021)

Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
por: Salehi, Zahra, et al.
Publicado: (2022)

Association of body mass index and physical activity with fatigue, depression, and anxiety among Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models
por: Hosseinnataj, Abolfazl, et al.
Publicado: (2023)

Neuronavigation: Principles, Clinical Applications and Potential Pitfalls
por: Khoshnevisan, Alireza, et al.
Publicado: (2012)

Significant Increase in the Prevalence of Multiple Sclerosis in Iran in 2011
por: Izadi, Sadegh, et al.
Publicado: (2014)

Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study
por: Mortazavi, Seyyed Hosein, et al.
Publicado: (2023)

Characteristics of COVID-19 in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis
por: Salehizadeh, Saeideh, et al.
Publicado: (2022)

Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
por: Azadvari, Mohaddeseh, et al.
Publicado: (2020)

Epidemiology of multiple sclerosis in Qom: Demographic study in Iran
por: Rezaali, Saeed, et al.
Publicado: (2013)

Blood Concentrations of Cadmium and Lead in Multiple Sclerosis Patients from Iran
por: Aliomrani, Mehdi, et al.
Publicado: (2016)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2021)

Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012
por: SAEI, Mahbubeh, et al.
Publicado: (2014)

Cerebral abscess complicating embolization of an arteriovenous malformation: Case report and review of litera
por: Khoshnevisan, Alireza, et al.
Publicado: (2014)

The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry
por: DEHGHANI, Rouhullah, et al.
Publicado: (2015)

Early-Onset Multiple Sclerosis: Reports of 300 Patients from Iran
por: Omrani, Fateme, et al.
Publicado: (2018)

The Relationship Between Social Support and Family Functioning Among Married Multiple Sclerosis Patients in Iran with the Mediating Role of Spiritual Experiences and Moral Foundations
por: Namvar, Hooman, et al.
Publicado: (2023)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Multiple sclerosis-A disease on a dramatically rising trend in Iran: Review of possible reasons
por: Sahraian, Mohammad Ali, et al.
Publicado: (2017)

SCCmec Genotypes of Methicillin-Resistant Staphylococcus aureus in Nasal Carriage of Multiple Sclerosis Patients in Iran
por: JAMSHIDI, Yasaman, et al.
Publicado: (2019)

Burden of multiple sclerosis in Iran from 1990 to 2017
por: Fattahi, Nima, et al.
Publicado: (2021)

Prevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran
por: Ayati, Nayyereh, et al.
Publicado: (2021)

The health burden of non-communicable neurological disorders in the USA between 1990 and 2017
por: Bazargan-Hejazi, Shahrzad, et al.
Publicado: (2020)

Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
por: Molazadeh, Negar, et al.
Publicado: (2023)

Month of Birth and the Incidence of Multiple Sclerosis in Southern Iran
por: Nikseresht, Alireza, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_niiedm9juqbb6t2gg7t11f922g